Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/avalanche-institutional-adoption-slows-down-with-market-dump-as-whaless-bet-coldwares-depin-will-outperform-traditional-defi/